United States · FDA National Drug Code directory
Rugby mometasone furoate nasal
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0536-1381_83cac9d3-1d41-4dab-895d-5215705746b7
- Product NDC
- 0536-1381
- Form
- SPRAY, METERED
- Composition / generic term
- mometasone furoate
- Labeler
- Rugby Laboratories
- Marketing category
- NDA
- Marketing start / end (source format)
- 20231011
- Source listing expiry
- 20261231
Source-listed ingredients
- MOMETASONE FUROATE MONOHYDRATE — 50 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, SPRAY in 1 CARTON (0536-1381-30) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY · 0536-1381-30
- 1 BOTTLE, SPRAY in 1 CARTON (0536-1381-70) / 60 SPRAY, METERED in 1 BOTTLE, SPRAY · 0536-1381-70
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →